Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
33
2.4.3 INDIGENOUS HEALING PRACTICES
Indigenous tribes all around the world have developed their own distinct traditional
medicine systems based on plant-based compositions. Native American traditional
medicine for example, uses herbs such as sage, cedar, and sweetgrass for purification rites
and healing. Similarly, ancient African medicinal practices, such as the use of African
cherry tree bark (Prunus africana) for prostate health, showcase the utilization of plant
formulations (Rashid et al., 2023).
2.5 DRUG DISCOVERY
Plants have long been recognized for their therapeutic capabilities in traditional medicine,
with diverse civilizations harnessing their healing potential for ages. These plants have a
diverse set of bioactive compounds that contribute to the development of new medications.
Obtaining crude extracts from the plants is one way of gaining these advantages. Crude
extracts are created by isolating the active components of plants with solvents in order
to concentrate their medicinal effects. These extracts, which can be utilized in tinctures,
oils, or powder form, are frequently used in traditional medicinal practices. The crude
extracts generated from traditional medicine plants are valuable resources for modern
medicine since they form the basis for the creation of novel medications and therapies
(Mukherjee, 2019). Crude extract generated from natural sources such as plants or organisms is an excellent starting point for bioactivity research. Following that, in-vitro and
in-vivo tests are performed to evaluate the extract’s possible biological effects. These are
two major methodologies used in scientific research to assess the bioactivity of diverse
substances such as medications, chemicals, or natural compounds (Nik Salleh et al., 2020).
These investigations aid scientists in understanding the impact of these compounds on
biological systems and can provide useful information about their possible applications
and safety profiles. We can continue to study the immense potential of natural medicines
for human health by understanding the interaction between traditional medicine plants and
their crude extracts. Traditional knowledge research is critical for advancing new drug
discoveries and creating new therapeutic approaches. These investigations contribute to
the pharmacological profile, bioavailability, and general safety of the extract. It gives a
thorough understanding of the plant’s bioactivity and therapeutic potential, establishing
the groundwork for future research and the potential development of novel drug discovery
(Figure 2.2).
2.6 ASPECTS OF DEVELOPING PLANT-BASED DRUGS
2.6.1 SELECTION CRITERIA FOR PLANTS
The following information should be considered while selecting the plant material to be
evaluated for investigation in the context of medication development:
34
1. Traditional medical systems or ethnomedicinal uses
2. Chemotaxis-based standards
3. Environmental observations
4. Random selection
2.6.2 PLANT MATERIAL AUTHENTICATION
Morphological and anatomical investigation is the primary way of verification based on
surface and sensorial properties. Fingerprinting establishes the foundation for a quick
assessment and orientation of the model. Thin layer chromatography (TLC) is the most
extensively utilized and cost-effective method while high-performance TLC is a more
advanced form of the former (Reich et al., 2008).
2.6.3 EXTRACTION METHODS
Natural products are chemical compounds that are physiologically active and are consequential against natural sources such as floras and faunas. Natural products are commonly
employed in both traditional and modern treatments. Man-made compounds will never be
able to compete with the variety and chemical complexity of naturally occurring substances
(Ahmed et al., 2019). The natural product’ s structural analysis must be performed both in a
free and complex form with the receptor. Isolating natural compounds from plants remains
a difficult task despite substantial breakthroughs in abstraction and parting techniques.
Operational structural illumination is performed via a number of hybrid techniques, such
as liquid chromatography–mass spectrometry/liquid chromatography nuclear magnetic
resonance, and has yielded outstanding cases of natural product identification prior to
separation (Seger et al., 2013).
2.6.4 ISOLATION AND STRUCTURE ELUCIDATION OF BIOACTIVE COMPONENTS
Both in-vivo and in-vitro investigations are critical in establishing a full understanding of
the biological effects and mechanisms of these substances in the field of bioactivity and
isolation as well as structure elucidation of bioactive components (Ghribi et al., 2015).
In-vitro investigations, which are conducted outside the living organism, provide
vital insights into the initial assessment of bioactivity by examining the interaction of
bioactive substances with cellular or biochemical systems. Cell cultures or isolated
enzymes are frequently used in these investigations, allowing for controlled experiments
and the exploration of specific molecular targets. In contrast, in-vivo investigations entail
evaluating the effects of bioactive substances on complete systems or organs within
living creatures such as animal models or human participants (Kusz et al., 2020). This
method provides a more comprehensive perspective, considering the various interactions
and physiological responses that might occur in a biological environment. Researchers
can link measured bioactivity with actual physiological responses by merging findings
35
from in-vitro and in-vivo experiments, offering a deeper knowledge of the systems
involved. Bioactive components isolation and structural elucidation are critical phases
in natural product chemistry and pharmaceutical development. Individual molecules
displaying biological activity such as plant extracts or microbial cultures are identified
from complicated mixtures and characterized by these techniques.
2.6.5 STANDARDIZATION OF PLANT FORMULATIONS
The process of creating consistent and reproducible quality parameters for herbal or plantbased goods is referred to as standardization of plant formulations. It entails developing
particular criteria and methods to verify that the formulation composition, potency, and
quality are uniform from batch to batch. The following are some important features of
standardizing plant formulations.
The first step is to authenticate the plant species that has been employed in the formulation. This
is significant since different plant species may have varying medicinal capabilities as well as
potential negative effects. For authentication, techniques such as macroscopic and microscopic
investigation, chemical profiling, and DNA testing are employed (Noviana et al., 2022).
Ensuring the quality of raw materials is essential for standardized formulations. This includes
setting standards for plant material selection and sourcing such as geographic origin, cultivation methods, harvesting time, and storage conditions. Raw materials must also be handled
and stored properly in order to keep their quality (World Health Organization, 2003).
Many plant formulations contain active chemicals that aid in the medicinal benefits. Standardization entails employing approved analytical procedures to determine the concentration or quantity of these active components. High-performance liquid chromatography , gas
chromatography , and spectrometry are examples of techniques that can be used (Kunle et al.,
2012).
Reference standards are used as benchmarks to assess the quality and potency of plant
formulations. These standards can be authentic plant material, isolated active compounds,
36
or validated chemical markers. Manufacturers can verify uniformity and potency by
comparing formulations to reference standards.
Standardization also involves defining and implementing consistent manufacturing
processes. This includes specifying procedures for extraction, purification, formulation,
and packaging. Standard operating procedures are developed to ensure that each step is
performed consistently, minimizing variations in the final product (Haider, 2006).
Standardization necessitates the implementation of strong quality assurance and
quality-control procedures. This includes testing raw materials, in-process samples, and
finished goods on a regular basis to ensure that they fulfill the quality requirements.
Several quality control procedures, such as physical, chemical, and microbiological
investigations are carried out to assess product quality and safety (Shruti and KutralamMuniasamy, 2023).
Regulatory requirements frequently influence the standardization of plant formulations.
Regulatory agencies may issue guidelines or monographs outlining the quality requirements for herbal products. Compliance with these rules is critical to ensure the safety and
efficacy of products (Sharma and Yadav, 2023).
Standardization is critical in toxicological research of plant compositions. It improves
stability and dependability in the composition and quality of plant-based products, allowing
for a more precise evaluation of their toxicological effects. Specic markers or active
components within plant formulations can be discovered and measured by standardization,
allowing researchers to establish a valid correlation between the chemical ingredients and
their possible toxicological effects. Furthermore, standardized techniques give a framework
for conducting toxicity studies, enabling the results to be comparable and reproducible across
different trials and research organizations. Overall, standardization serves as an important
link between the chemical composition of plant formulations and their toxicological
effects, ensuring a robust and methodological approach to assessing their safety proles.
Despite a lengthy antiquity of conventional usage and anecdotal evidence, not all plant-
based products have been thoroughly conrmed. As a result, proceed with caution and
seek the counsel of healthcare professionals for conrmation based on available scientic
data. To proceed with drug research and development process, an active molecule that can
interact with specic targets is required. These compounds can be discovered by screening
substances in a systematic or random manner. These compounds of interest originate in two
37
ways: synthetic chemistry and natural sources. For identication, preclinical and clinical
development of pharmaceuticals from plants, numerous critical processes, including plant
selection, extraction, isolation, and characterization, are necessary prior to biological
testing (Goyal et al., 2020).
The role of traditional knowledge in drug discovery from plants has been of immense
importance throughout history and continues to play a signicant role in modern scientic
research. Traditional knowledge refers to information, practices, and beliefs of indigenous
societies that have been passed down orally for generations. This gathered knowledge has
provided useful insights into the qualities and applications of numerous plants, as well as
their potential medical advantages. Plants have been utilized medicinally for thousands of
years by many cultures all over the world. Traditional healers and indigenous cultures have
investigated the impact of plants on human health and accumulated a wealth of knowledge
on their therapeutic applications. This knowledge includes specic plant species, preparation methods, dosage, and the treatment of various ailments. Conventional remedy structures such as Ayurveda, TCM, and Native American herbalism, among others, are based on
years of experience with medicinal plants. With the improvement of scientic approaches,
there has been an increased interest in studying the healing latent of plants based on
traditional knowledge. Ethnobotany, an approach that blends anthropology with botany,
has evolved as a discipline dedicated to investigating the interaction between people and
plants, with special emphasis on indigenous knowledge systems. Traditional healers and
indigenous people collaborate with ethnobotanical researchers to document and examine
herbs and remedies used in traditional medicine. Traditional knowledge is important in
aiding scientists in the development of new drugs. Some of the modern medications that
derive from plants have been described in Table 2.2.
Artemisinin, an antimalarial medication produced from the plant Artemisia annua,
was found using traditional Chinese herbal medicine practices. Similarly, the painkiller
morphine is produced from the Opium poppy, a plant that has been known and used for
centuries for its analgesic effects. T raditional knowledge offers researchers crucial informa-
tion related to potentially active molecules, making it a signicant beginning point in the
drug-discovery process. Traditional healers often have a thorough awareness of the local
ora and can identify medicinal herbs. They can provide useful information regarding the
plant parts used, the extraction processes applied, and any associated traditional practices.
This knowledge aids in the identication of bioactive molecules, thereby saving time and
resources during the early phases of drug research. Furthermore, traditional knowledge
includes details about the safety, toxicity, and potential adverse effects of plant-based
medicines. Over decades, indigenous communities have amassed vast knowledge about
the administration and dose of therapeutic herbs. This knowledge is critical for scientists
to ensure the safety and efcacy of future plant-derived medications. However, it is critical
to proceed with caution and respect when integrating traditional knowledge and modern
medication research. It is critical to respect indigenous people’s intellectual property rights,
cultural traditions, and ethical issues. Mutual trust, respect, and equitable benet-sharing
should underpin collaboration. Indigenous groups should participate in the decision-making
so that they are made aware about how their knowledge is used and shared.
38
TABLE 2.2 Drugs Derived from Different Plants along with Their Potential Uses
S. No. Drug Scientific Name Common Name Uses
1. Taxol (paclitaxel)
2. Aspirin
(acetylsalicylic acid)
3. Digoxin
4. Artemisinin
5. Morphine
6. Vinblastine and
Vincristine
7. Quinine
8. Reserpine
9. Etoposide
Taxus brevifolia
Salix spp.
Digitalis purpurea
Artemisia annua
Papaver somniferum
Catharanthus roseus
Cinchona spp.
Rauvolfia serpentina
Podophyllum peltatum
Pacific yew tree Anticancerous
Willow Pain reliever, anti-inflammatory
agent, and antiplatelet drug
Foxglove plant Treatment of heart failure and
certain heart rhythm abnormalities
Sweet wormwood Antimalarial
Poppy Pain reliever and a prototype
opioid analgesic
Madagascar
periwinkle plant
Cinchona tree Antimalarial
Indian snakeroot
plant
Mayapple plant Anticancerous
Anticancerous
Antihypertensive and antipsychotic
⏎
2.7 CONCLUSIONS
Traditional knowledge is critical in the discovery of plant-based drugs. The collected
wisdom of indigenous civilizations provides a large library of information on the therapeutic
properties and uses of diverse plants. Integrating ancient knowledge with current scientific
approaches can lead to the development of novel medications, providing potential cures
for a variety of disorders. However, it is critical to approach this relationship ethically and
respectfully; ensuring indigenous groups’ rights and interests are preserved and respected.
W e can leverage the potential of traditional knowledge while honoring indigenous cultures’
contributions to the field of medicine by promoting a collaborative and inclusive approach.
KEYWORDS
• traditional knowledge
• ethnomedicine
• Ayurvedic medicine
• thin layer chromatography
• ethnobotany
REFERENCES
Abhishek, K.; Saksham, R.; Deepti, K.; Rao, N. G. R.; Surya, P.; Vinay , K.; V idhu S.; Priya B. Medicinal plants
and herbal formulations ameliorating neurodegeneration: Remedies combating Parkinson’s and Alzheimer’s
disease. J. Young Pharm. 2023, 15, 194–200.
39
Afendi, F. M.; Okada, T.; Yamazaki, M.; Hirai-Morita, A.; Nakamura, Y.; Nakamura, K.; Ikeda, S.; Takahashi,
H.; Altaf-Ul-Amin, M.; Darusman, L. K.; Saito, K. KNApSAcK family databases: integrated metabolite–
plant species databases for multifaceted plant research. Plant Cell Physiol. 2012, 53(2), 1.
Ahmed, S.; Rattanpal, H. S.; Gul, K.; Dar, R. A.; Sharma, A. Chemical composition, antioxidant activity and
GC-MS analysis of juice and peel oil of grapefruit varieties cultivated in India. J. Integr. Agric. 2019, 18(7),
1634–1642.
Balkrishna, A.; Singh, S.; Srivastava, D.; Mishra, S.; Sharma, S.; Mishra, R.; Arya, V. A systematic review on
traditional, Ayurvedic, and herbal approaches to treat solar erythema. Int. J. Dermatol. 2023, 62, 322–336.
Ball, J. Identity and knowledge in Indigenous young children’s experiences in Canada. Child. Educ. 2012,
88(5), 286–291.
Berkes, F.; Colding, J.; Folke C. Rediscovery of traditional ecological knowledge as adaptive management.
Ecol. Appl. 2000, 10, 1251–1262.
Chang, S. S.; Huang, H.J..; Chen, C. Y. C. Two birds with one stone? Possible dual-targeting H1N1 inhibitors
from traditional Chinese medicine. PLoS Comput. Biol. 2011, 7 (12), 1002315.
Chaudhary, S.; Magar, G. T.; Sah, S. N.; Parajuli, S. Ethnic plants of Tharu community of Eastern Nepal. Int.
J. Appl. Sci. Biotechnol. 2020, 8(2), 223–230.
Cragg, G. M.; Newman, D. J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005, 100, 72–79.
Dachev, Y.; Panov, A. T raditional navigation in e-Navigation context. 18th Annual General Assembly AGA. 2017,
pp. 106–115.
Dash, B.; Kashyap, L. Diagnosis and Treatment of Diseases in Ayurveda: Based on Ayurveda Saukhyam of
Ṭoḍarananda (No. 7). Concept Publishing Company; 1981.
Davidson-Hunt, I. J.; Turner, K. L.; Mead, A. T. P.; Cabrera-Lopez, J.; Bolton, R.; Idrobo, C. J.; Miretski, I.;
Morrison, A.; Robson, J. P. Biocultural design: A new conceptual framework for sustainable development in
rural indigenous and local communities. SAPIENS. 2012, 5, 2.
Drahos, P . When cosmology meets property: Indigenous people’ s innovation and intellectual property. Prometheus.
2011, 29(3), 233–252.
Dutfield, G. Opinion: Why traditional knowledge is important in drug discovery . Futur e Med. Chem. 2010, 2(9),
01405–1409.
Ghribi, L.; Waffo-Teguo, P.; Cluzet, S.; Marchal, A.; Marques, J.; Merillon, J. M.; Jannet, H. B. Isolation and
structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L. Bioorg.
Med. Chem. Lett. 2015, 25(18), 3825–3830.
Goyal, R. K.; Majeed, J.; Tonk, R.; Dhobi, M.; Patel, B.; Sharma, K.; Apparsundaram, S. Current targets and
drug candidates for prevention and treatment of SARS-CoV -2 (COVID-19) infection. Rev. Cardiovasc. Med.
2020, 21(3), 365–384.
Gu, J.; Gui, Y.; Chen, L.; Y uan, G.; Xu, X. CVDHD: A cardiovascular disease herbal database for drug discovery
and network pharmacology. J. Cheminformatics, 2013, 5(1), 1–6.
Haider, S. I. Validation Standard Operating Procedures: A Step by Step Guide for Achieving Compliance in the
Pharmaceutical, Medical Device, and Biotech Industries. CRC Press. 2006, 3, pp. 160–188.
Hamanaka, N.; Kan, H.; Yokoyama, Y.; Okamoto, T .; Nakashima Y and Kawana, T. Disturbances with hiatuses
in high-latitude coral reef growth during the Holocene: Correlation with millennial-scale global climate
change. Glob. Planet. Change. 2012,
Hasnawati, L.; Nadliroh, A. Diversity and pesantren values as the basis of education in Malaysia and Indonesia.
Dawuh Guru: Jurnal Pendidikan MI/SD. 2023, 3(1), 1–12.
Iaccarino, M. Science and culture: Western science could learn a thing or two from the way science is done in
other cultures. EMBO Rep. 2003, 4(3), 220–223.
Jasmine, B.; Singh, Y.; Onial, M.; Mathur, V. B. Traditional knowledge systems in India for biodiversity
conservation. Indian J. Tradit. Knowl. 15(2), 304–312.
Jensen, K.; Panagiotou, G.; Kouskoumvekaki, I. NutriChem: A systems chemical biology resource to explore
the medicinal value of plant-based foods. Nucleic Acids Res. 2015, 43, 940–945.
Kimmerer, R. Braiding Sweetgrass: Indigenous Wisdom, Scientific Knowledge and the Teachings of Plants.
Milkweed edn. 2013, pp. 308–330.
Kola-Olusanya, A. Environmental conservation: Espousing indigenous knowledge system as a model for caring
for the Earth. J. Educ. Soc. Res. 2012, 2, 359–367.
80, 21–35.
40
Kunle, O. F .; Egharevba, H. O.; Ahmadu, P. O. Standardization of herbal medicines—A review . Int. J. Biodivers.
Conserv. 2012, 4(3), 101–112.
Kusz, N.; Hohmann, J.; Redei, D. Isolation and structure elucidation of bioactive compounds from Euphorbia
species (Doctoral dissertation, University of Szeged), 2020.
Lagunin, A. A.; Goel, R. K.; Gawande, D. Y.; Pahwa, P.; Gloriozova, T. A.; Dmitriev , A. V.; Ivanov, S. M.; Rudik,
A. V.; Konova, V. I.; Pogodin, P V.; Druzhilovsky, D. S. Chemo-and bioinformatics resources for in silico drug
discovery from medicinal plants beyond their traditional use: A critical review. Nat. Prod. Rep. 2014, 31(11),
1585–1611.
Lawless, K. A.; Brown, S. W.; Mills, R.; Mayall, H. J. Knowledge, interest, recall and navigation: A look at
hypertext processing. J. Lit. Res. 2003, 35(3), 911–934.
Lesney, M. S. Nature’s pharmaceuticals. Today’s Chemist at Work. American Chemical Society. Nat. Pharma.
2004, pp. 27–32.
Magni, G. Indigenous knowledge and implications for the sustainable development agenda. Eur. J. Educ. 2017,
52(4), 437–447.
Mahmood, A.; Mahmood, A.; Malik, R. N.; Shinwari, Z. K. Indigenous knowledge of medicinal plants from
Gujranwala district, Pakistan. J. Ethnopharmacol. 2013, 148 (2):714–723.
Maina, C. K. Traditional knowledge management and preservation: Intersections with Library and Information
Science. Int. Inf. Libr. Rev. 2012, 44(1), 13–27.
Mukherjee, P. K. Quality Control and Evaluation of Herbal Drugs: Evaluating Natural Products and
Traditional Medicine. Elsevier. Susan Dennis Acquisition Editor. 2019, pp. 53–71.
Nadkarni, K. M. Indian Materia Medica, 3rd edn. Vol. 2, Rev. by A. K. Nadkarni. Popular Book Depot, Bombay,
India, 1955.
Nik Salleh, N. N. H.; Othman, F. A.; Kamarudin, N. A.; Tan, S. C. The biological activities and therapeutic
potentials of baicalein extracted from Oroxylumindicum: A systematic review. Molecules. 2020, 25(23), 5677.
Noor, N. A. M.; Abd Razak, N. A. Overcoming learning challenges during the COVID-19 pandemic: Traditional
knowledge as an educational alternative for the Orang Asli. ICR J. 2022, 13(1), 31–50.
Noviana, E.; Indrayanto, G.; Rohman, A. Advances in fingerprint analysis for standardization and quality
control of herbal medicines. Front. Pharmacol. 2022, 13, 1–3.
Parasuraman, S.; Perumal, P. Siddha, an indigenous medical system of peninsular India. In: Herbal Medicine
in India: Indigenous Knowledge, Practice, Innovation and Its Value. 2020, pp. 9–21.
Pathania, S.; Ramakrishnan, S.M.; Bagler, G. Phytochemica: A platform to explore phytochemicals of medicinal
plants. Database. 2015a, 20, 15.
Pathania, S.; Ramakrishnan, S. M.; Randhawa, V.; Bagler, G. SerpentinaDB: A database of plant-derived
molecules of Rauvolfiaserpentina. BMC Complement. Altern. Med. 2015b, 15(1), 1–8.
Patwardhan, B.; Vaidya, A.D.; Chorghade, M. Ayurveda and natural products drug discovery. Curr. Sci. 2004,
86, 789–799.
Permatasari, A.; Dhewanto, W.; Dellyana, D. The role of traditional knowledge-based dynamic capabilities to
improve the sustainable performance of weaving craft in Indonesia. J. Enterp. Communities: People Places
Glob. Econ. 2023,
Piercey, M. Traditional indigenous knowledge: An ethnographic study of its application in the teaching and
learning of traditional Inuit drum dances in Arviat, Nunavut. Critical Perspectives in Canadian Music
Education. Wilfrid Laurier University Press: Waterloo, ON, 2012, Vol. 86, pp. 71–87.
Poorna, R. L.; Mymoon, M.; Hariharan, A. Preservation and protection of traditional knowledge–diverse
documentation initiatives across the globe. Curr. Sci. 2014, 107, 1240–1246.
Rashid, M.; Nguyen, J.; Foulds, J. L.; Dennett, L.; Cardinal, N.; Forgie, S. E. A scoping review of Indigenous
health curricular content in graduate medical education. J. Grad. Med. Educ. 2023, 15(1), 24–36.
Reich, E.; Schibli, A.; DeBatt, A. Validation of high-performance thin-layer chromatographic methods for the
identification of botanicals in a cGMP environment. J. AOAC Int. 2008, 91(1), 13–20.
Reyes-Garcia, V.; Aceituno-Mata, L.; Calvet-Mir , L.; Garnatje, T.; Gomez-Baggethun, E.; Lastra, J. J.; Ontillera,
R.; Parada, M.; Rigat, M.; Valles, J.; Vila S. Resilience of traditional knowledge systems: The case of
agricultural knowledge in home gardens of the Iberian Peninsula. Glob. Environ. Change. 2014, 24, 223–231.
Reyes-Garcia, V. The relevance of traditional knowledge systems for ethnopharmacological research:
Theoretical and methodological contributions. J. Ethnobiol. Ethnomed. 2010, 6(1), 1–12.
17(3), 664–683.
41
Seger, C.; Sturm, S.; Stuppner, H. Mass spectrometry and NMR spectroscopy: Modern high-end detectors
for high resolution separation techniques—state of the art in natural product HPLC-MS, HPLC-NMR, and
CE-MS hyphenations. Nat. Prod. Rep. 2013, 30(7), 970–987.
Selemani, I. S. Indigenous knowledge and rangelands’ biodiversity conservation in Tanzania: Success and
failure. Biodivers. Conserv. 2020, 29(14), 3863–3876.
Sen, S.; Chakraborty, R. Toward the integration and advancement of herbal medicine: A focus on traditional
Indian medicine. Botanics: Targets Therapy. 2015, 5, 33–44.
Sen, S.; Chakraborty, R. Revival, modernization and integration of Indian traditional herbal medicine in clinical
practice: Importance, challenges and future. J. Trad. Complement. Med. 2017, 7(2), 234–244.
Shah, S.; Bhat, J. A. Ethnomedicinal knowledge of indigenous communities and pharmaceutical potential of
rainforest ecosystems in Fiji Islands. J. Integr. Med. 2019, 17(4), 244–249.
Sharma, B.; Yadav, D. K. Chromatographic and their hyphenated techniques in quality-based standardization of
medicinal plants: Current scenario and future perspectives. S. Afr. J. Bot. 2023, 157, 467–483.
Sheng-Ji, P. Ethnobotanical approaches of traditional medicine studies: Some experiences from Asia. Pharm.
Biol. 2001, 39, 74–79.
Shruti, V. C.; Kutralam-Muniasamy, G. Blanks and bias in microplastic research: Implications for future quality
assurance. Trends Environ. Anal. Chem. 2023, 38, 203.
Singh, N.; T ang, Y.; Zhang, Z.; Zheng, C. COVID-19 waste management: Effective and successful measures in
Wuhan, China. Resour. Conserv. Recycl. 2020, 163, 105071.
Singh, R. P.; Ibrahim, M. H.; Esa, N.; Iliyana, M. S. Composting of waste from palm oil mill: A sustainable
waste management practice. Rev. Environ. Sci. Biotechnol. 2010, 9, 331–344.
Sujata, W . D., W arjeet, L. S. Studies on the uses of some plants for medicinal and dyeing properties. Int. J. Chem.
2016, 5(1), 93–102.
Sunder, M. The invention of traditional knowledge. Law Contemp. Probs. 2007, 70, 97.
Thomas, K.; Hardy, R. D.; Lazrus, H.; Mendez, M.; Orlove, B.; Rivera-Collazo, I.; Roberts, J. T.; Rockman, M.;
Warner, B. P.; Winthrop, R. Explaining differential vulnerability to climate change: A social science review.
Wiley Interdiscip. Rev. Clim. Change. 2019, 10(2), 565.
Turner , N. J.; Ignace, M. B..; Ignace, R. Traditional ecological knowledge and wisdom of aboriginal peoples in
British Columbia. Ecol. Appl. 2000, 10(5), 1275–1287.
Uprety, Y.; Asselin, H.; Bergeron, Y.; Doyon, F.; Boucher, J. F. Contribution of traditional knowledge to
ecological restoration: practices and applications. Ecoscience. 2012, 19(3), 225–237.
W angkheirakpam, S. Traditional and folk medicine as a target for drug discovery. In: Mandal, S. C.; Mandal, V.;
Konishi, T. (Eds.), Natural Pr oducts and Drug Discovery an Integrated Approach. Elsevier. 2018, pp. 29–56.
Williams, T.; Hardison, P . Culture, law , risk and governance: contexts of traditional knowledge in climate change
adaptation. Climatic Change. 2013, 120(3), 531–544.
World Health Organization, WHO Guidelines on Good Agricultural and Collection Practices [GACP] for
Medicinal Plants
Xue, R.; Fang, Z.; Zhang, M.; Y i, Z.; W en, C., Shi T . TCMID: T raditional Chinese medicine integrative database
for herb molecular mechanism analysis. Nucleic Acids Res. 2012, 41, 1089–D1095.
Zeng, X.; Zhang, P.; He, W.; Qin, C.; Chen, S.; Tao, L.; Wang, Y.; Tan, Y.; Gao, D.; Wang, B., Chen, Z.
NP ASS: Natural product activity and species source database for natural product research, discovery and tool
development. Nucleic Acids Res. 2018, 46, 1217–1222.
Zeng, X.; Zhang, P .; W ang, Y.; Qin, C.; Chen, S.; He, W .; Tao, L., Tan, Y.; Gao, D.; Wang, B., Chen, Z. CMAUP:
A database of collective molecular activities of useful plants. Nucleic Acids Res. 2019, 47, 1118–1127.
Zerabruk, S., Yirga, G. Traditional knowledge of medicinal plants in Gindeberet district, Western Ethiopia. S.
Afr. J. Bot. 2012, 78, 165–169.
Zhang, R. Z.; Yu, S. J.; Bai, H., Ning, K. TCM-Mesh: The database and analytical system for network
pharmacology analysis for TCM preparations. Sci. Rep. 2017, 7(1), 2821.
Zhao, X.; Tan, X.; Shi, H.; Xia, D. Nutrition and traditional Chinese medicine (TCM): A system’s theoretical
perspective. Eur. J. Clin. Nutr. 2021, 75(2), 267–273.
. World Health Organization, 2003.
